Clinicopathological characteristics and treatment of rhabdoid glioblastoma

Journal of Neurosurgery

Volumn 119, Issue 2, 2013, Pages 412-419

  Babu, Ranjith ^a   Hatef, Jeffrey ^a   McLendon, Roger E ^a   Cummings, Thomas J ^a   Sampson, John H ^a   Friedman, Allan H ^a   Adamson, Cory ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Characteristics; Genetic; Oncology; Rhabdoid glioblastoma; Survival; Treatment

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; INTERLEUKIN 13; LOMUSTINE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TEMOZOLOMIDE;

ADULT; ARTICLE; ATAXIC APHASIA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CRANIOTOMY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; HEADACHE; HEMIPARESIS; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; LUNG METASTASIS; MALE; MEDICAL RECORD REVIEW; MEMORY DISORDER; MENINX; METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RHABDOID GLIOBLASTOMA; SCALP METASTASIS; SHORT TERM MEMORY; STEREOTACTIC BIOPSY; TEMPORAL LOBE;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CRANIOTOMY; FEMALE; FRONTAL LOBE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PARIETAL LOBE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84881171715     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.3.JNS121773     Document Type: Article

References (33)

1. Bannykh SI, Perry A, Powell HC, Hill A, Hansen LA: Malignant rhabdoid meningioma arising in the setting of preexisting ganglioglioma: A diagnosis supported by fluorescence in situ hybridization. Case report. J Neurosurg 97:1450-1455, 2002 (Pubitemid 35424305)
2. Beckwith JB, Palmer NF: Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 41:1937-1948, 1978 (Pubitemid 8335406)
3. Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, et al: The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 62:323-328, 2002 (Pubitemid 34074022)
4. Bikowska B, Grajkowska W, Józwiak J: Atypical teratoid/rhabdoid tumor: short clinical description and insight into possible mechanism of the disease. Eur J Neurol 18:813-818, 2011
5. Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, et al: Multiple resections for patients with glioblastoma: prolonging survival. Clinical article. J Neurosurg 118:812-820, 2013
6. Chamberlain MC: Bevacizumab for the treatment of recurrent glioblastoma. Clin Med Insights Oncol 5:117-129, 2011
7. Erickson ML, Johnson R, Bannykh SI, de Lotbiniere A, Kim JH: Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors. J Neurooncol 74:311-319, 2005 (Pubitemid 41444500)
8. Friedman HS, Kerby T, Calvert H: Temozolomide and treatment of malignant glioma. Clin Cancer Res 6:2585-2597, 2000 (Pubitemid 30482092)
9. Fung KM, Perry A, Payner TD, Shan Y: Rhabdoid glioblastoma in an adult. Pathology 36:585-587, 2004
10. He MX, Wang JJ: Rhabdoid glioblastoma: case report and literature review. Neuropathology 31:421-426, 2011
11. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005 (Pubitemid 40349502)
12. Ino Y, Silver JS, Blazejewski L, Nishikawa R, Matsutani M, von Deimling A, et al: Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. J Neuropathol Exp Neurol 58:881-885, 1999 (Pubitemid 29372842)
13. Kitange GJ, Carlson BL, Schroeder MA, Grogan PT, Lamont JD, Decker PA, et al: Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro Oncol 11:281-291, 2009
14. Kleihues P, Ohgaki H: Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol 1:44-51, 1999
15. Kleinschmidt-DeMasters BK, Alassiri AH, Birks DK, Newell KL, Moore W, Lillehei KO: Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6. Am J Surg Pathol 34:341-354, 2010
16. Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, Lillehei KO: Characterization of glioblastomas in young adults. Brain Pathol 16:273-286, 2006
17. Lath R, Unosson D, Blumbergs P, Stahl J, Brophy BP: Rhabdoid glioblastoma: A case report. J Clin Neurosci 10:325-328, 2003 (Pubitemid 36713404)
18. MacDonald TJ: Aggressive infantile embryonal tumors. J Child Neurol 23:1195-1204, 2008
19. Momota H, Iwami K, Fujii M, Motomura K, Natsume A, Ogino J, et al: Rhabdoid glioblastoma in a child: case report and literature review. Brain Tumor Pathol 28:65-70, 2011
20. Mutou J, Hirose Y, Ikeda E, Yoshida K, Nakazato Y, Kawase T: Malignant brain tumor with rhabdoid features in an adult. Neurol Med Chir (Tokyo) 51:449-454, 2011
21. Nagai S, Kurimoto M, Ishizawa S, Hayashi N, Hamada H, Kamiyama H, et al: A rare astrocytic tumor with rhabdoid features. Brain Tumor Pathol 26:19-24, 2009
22. Oda Y, Tsuneyoshi M: Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 56:287-295, 2006 (Pubitemid 43725396)
23. Ohgaki H, Kleihues P: Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445-1453, 2007 (Pubitemid 47339290)
24. Oskam NT, Bijleveld EH, Hulsebos TJ: A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Int J Cancer 85:336-339, 2000 (Pubitemid 30030405)
25. Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA: INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 18:951-958, 2005 (Pubitemid 41059956)
26. Pimentel J, Silva R, Pimentel T: Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation. J Neurooncol 61:121-126, 2003 (Pubitemid 36253657)
27. Rodriguez FJ, Scheithauer BW, Giannini C, Bryant SC, Jenkins RB: Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: A comparative morphologic and molecular genetic study. Cancer 113:2779-2789, 2008
28. Rorke LB, Packer RJ, Biegel JA: Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56-65, 1996 (Pubitemid 26195038)
29. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, et al: Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491-1499, 2005
30. Tsai CY, Wong TT, Lee YH, Chao ME, Lin SC, Liu DJ, et al: Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity. Am J Surg Pathol 36:128-133, 2012
31. Wick MR, Ritter JH, Dehner LP: Malignant rhabdoid tumors: A clinicopathologic review and conceptual discussion. Semin Diagn Pathol 12:233-248, 1995
32. Wyatt-Ashmead J, Kleinschmidt-DeMasters BK, Hill DA, Mierau GW, McGavran L, Thompson SJ, et al: Rhabdoid glioblastoma. Clin Neuropathol 20:248-255, 2001 (Pubitemid 33081708)
33. Yamamoto J, Takahashi M, Nakano Y, Soejima Y, Saito T, Akiba D, et al: Rapid progression of rhabdoid components of a composite high-grade glioma and rhabdoid tumor in the occipital lobe of an adult. Brain Tumor Pathol 29:113-120, 2012